Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> VACCINE Latest News

FEB 01, 2013 - Yahoo! News

A Must Read - Share

Merck beats forecast for fourth quarter, cautious on 2013

(Reuters) - Merck & Co Inc's quarterly results beat estimates, helped by strong sales of its Januvia diabetes drug and Gardasil vaccine against cervical cancer, but the company forecast 2013 profit at the low end of expectations. Merck also said Friday it will not seek approval until next year for osteoporosis treatment odanacatib, a delay that Jefferies analyst Jeffrey Holford said "will disappoint many investors," and hurt shares today. The stock fell 1.5 percent to $42.60 before the market opened. The No. 2 U.S. drugmaker said it earned $1. ...

Tags: Merck beats forecast for fourth quarter, cautious on 2013,  Vaccine Latest News